J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 08, 2019.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09-09-2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09-09-2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA approval by US FDA'.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a Copy of Post Buyback Public Advertisement for Buy back of Equity Shares of J.B. Chemicals & Pharmaceuticals Limited pursuant to the provisions of Regulation 19(7) of SEBI (Buy Back of Securities) Regulations, 1998.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 02, 2018, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 02, 2018 for approving Unaudited Financial Results for the quarter ended on September 30, 2018..

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pre-approval inspection by US FDA '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter of Offer -Proposed Buyback of Company'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Buy-back updates: Filing of Draft Letter of Offer'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 04, 2018

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 04, 2018. Further, the company has informed the Exchange regarding voting results.

Vivro Financial Services Private Limited has submitted to the Exchange a Copy Certified True Copy of the Resolution Passed By the Board of Directors at its meeting held on August 31, 2018 along with Public Announcement For The Attention Of Equity Shareholders/ Beneficial Owners Of Equity Shares Of the Company For Buy-Back Of Equity Shares Through The Tender Offer Route As Prescribed Under The Securities And Exchange Board Of India (Buy- Back Of Securities) Regulations, 1998, As Amended.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a Copy of Public Announcement For The Attention Of Equity Shareholders/ Beneficial Owners Of Equity Shares Of the Company For Buy-Back Of Equity Shares Through The Tender Offer Route As Prescribed Under The Securities And Exchange Board Of India (Buy- Back Of Securities) Regulations, 1998, As Amended.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as September 12, 2018 To determine the entitlement and names of Equity Shareholders, who shall be entitled to participate in the proposed offer for Buy-back of up to 33,33,333 Equity Shares of the Company at the price of Rs.390/- per Equity Share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding�� Copy of Board Resolution approving Buy-Back.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Intimation of Record Date under Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company has, at its meeting held on August 31, 2018 approved the Buy-back of up to 33,33,333 fully paid up Equity Shares of face value of Rs. 2/- each by the Company (representing 3.99% of the total paid up Equity Share capital of the Company) at a price of Rs 390/- (Rupees Three Hundred and Ninety only) per Equity Share payable in cash for a total consideration not exceeding Rs.130/- crores (Rupees One Hundred and Thirty crores only) (excluding transaction costs such as fees, brokerage, taxes,

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 31, 2018 - Buy-back of Equity Shares by the Company

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 10, 2018, titled "Press Release ".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 10, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from August 29, 2018 to September 4, 2018 (both days inclusive) for the purpose of To ascertain eligibility of the beneficial owners/ shareholders for dividend for FY 2017-18, if declared at the annual general meeting.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Date of payment of dividend

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Sub : Notice of Annual General Meeting In compliance with the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the notice of the Annual General Meeting of the Company to be held on September 4, 2018.'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015Ref: Update on Explosion/Fire at API Plant at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Sub: Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015Ref: Explosion/Fire at API Plant at Panoli, GujaratThis is to inform you that one reactor has exploded/caught fire this morning at Company��s API manufacturing unit at Panoli, Gujarat in the course of manufacturing process. This has damaged surrounding civil structure and equipment. The extent of damage/loss is not known at present. The buildings and plant and machinery at the said unit are fully covered by insurance. We

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has opted to submit to the Exchange standalone financial results during the financial year 2018-19. Accordingly, the Company shall submit standalone financial results as contemplated in Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a Copy of Revised Audited financial results for the year ended on March 31, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 25, 2018, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2018, recommended Final Dividend of 2.00 per equity share.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of API Manufacturing facility at Panoli, Gujarat '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Notice in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF). '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Sub: Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015Ref: Revocation of Closure Order for Formulations Facility at DamanWe refer to disclosure made on April 19, 2018 regarding an order from Office of Member Secretary, Pollution Control Committee, Daman directing the closure of the Company��s formulation manufacturing facility at Daman (��the said Closure order��). We now wish to inform you that the said Closure order has been revoked by the issuing authority. The Company h

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'The Company has received an order from Office of Member Secretary, Pollution Control Committee, Daman dated April 18, 2018 directing the closure of the Company��s formulation manufacturing facility at Daman (��the said order��) on the ground of alleged deviation of standards of treated waste water released from ETP outlet of the said facility. The Company does not accept the analytical results obtained by the said authority. The Company is taking all necessary steps so as to resume operations at the said facility in li

J. B. Mody, D. B. Mody , S. B. Mody has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 09, 2018.